We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AMZN:NASDAQAmazon.com, Inc. analysis

Data as of Oct 8, 2026 - not real-time

Latest price
$259.92
Risk: medium
5/10Medium risk

Summary

At $259.92, Amazon.com, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Momentum indicators put RSI at 58.5 (neutral) with MACD reading bullish. Recent trading has carved out support near $244.30 and resistance around $260.14.
The shares look fair at 20.9 times earnings, though no sector average was available for comparison. Analyst price targets sit 27.6% above the current price. Revenue is growing at 19.6% on a 17.4% profit margin.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 24.7%, a beta of 1.43 and a maximum drawdown of 21.7%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top market events

  • Andvari Associates, an investment management firm, released its second-quarter 2026 investor letter.
  • Amazon’s valuation has become a topic of discussion as the stock lags other major AI names.
  • AMZN tokenized stock is coiling at $260.76 with whales positioned 61.4% long and Wall Street's 59-analyst consensus...

Market outlook

Short term

< 1 year

Positive

Model confidence5/105 out of 10

Key factors

  • Trading above the 200-day average of 241.85
  • MACD momentum is positive
  • Maximum drawdown of 21.7%

Medium term

1–3 years

Positive

Model confidence6/106 out of 10

Key factors

  • Trading above the 200-day average of 241.85
  • Analyst targets imply +27.6% versus the current price
  • MACD momentum is positive

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • Analyst targets imply +27.6% versus the current price
  • Profit margin of 17.4% is healthy
  • Revenue growth of +19.6%

Key metrics

Financial health

Revenue Growth19.60%
Profit Margin17.44%
P/E Ratio20.9
ROE30.56%
ROA6.59%
Debt/Equity45.62
P/B Ratio5.1
Op. Cash Flow$161.4B
Free Cash Flow$3.2B

Technical analysis

TrendNeutral
RSI58.5
Support$244.30
Resistance$260.14
MA 20$251.63
MA 50$258.01
MA 200$241.85
MACDBullish
VolumeStable
Fear & Greed Index94.5

Valuation

Target Price$331.53
Upside/Downside27.55%
GradeFair
TypeGrowth

Risk assessment

Beta1.43
Volatility24.75%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.